Search - tctmd.com

Displaying 541 - 560 of 609

Sort: Relevancy | Date

Presentation TCT 2014

Cellular Nanotechnology in STEMI

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Jonathan Leor

September 15, 2014

Presentation TCT 2014

Microvesicles: Multiple Effects of Cord-Blood CD133+ Cells

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Wojtek Wojakowski

September 15, 2014

Presentation TCT 2014

Cell Matrix and Endothelial Function: Impact of Hyperglycemia

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Elazer R. Edelman

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

Angina Tops Ischemia as Predictor of Stable CAD Outcomes

Todd Neale

August 20, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

L.A. McKeown

February 06, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

Presentation

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Presenter: 222318|Tracy Wang

February 03, 2014

News Daily News

COURAGE Substudy: Anatomy Trumps Ischemia for Predicting Outcomes

January 15, 2014

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

Advertisement

Cellular Nanotechnology in STEMI

Microvesicles: Multiple Effects of Cord-Blood CD133+ Cells

Cell Matrix and Endothelial Function: Impact of Hyperglycemia

Enhanced Effects of Primed Peripheral Monocytes

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Angina Tops Ischemia as Predictor of Stable CAD Outcomes

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Apixaban Cost-Effective Compared with Warfarin or Aspirin

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

COURAGE Substudy: Anatomy Trumps Ischemia for Predicting Outcomes

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content